NovoCure Limited (NVCR) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
NO. 4 THE FORUM ST. HELIER, JE2 4UF |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 910,616 | 969,425 | 937,700 | 842,576 | 326,090 | 245,878 | |||
| Cash and cash equivalents | 240,821 | 115,326 | 208,802 | 234,674 | 177,321 | 140,622 | |||
| Short-term investments | 669,795 | 854,099 | 728,898 | 607,902 | 148,769 | 105,256 | |||
| Restricted cash and investments | 1,743 | 508 | 807 | 11,499 | 2,095 | 2,134 | |||
| Receivables | 61,221 | 86,261 | 93,567 | 96,699 | 58,859 | 36,523 | |||
| Inventory, net of allowances, customer advances and progress billings | 38,152 | 29,376 | 24,427 | 27,422 | 23,701 | 22,555 | |||
| Inventory | 38,152 | 29,376 | 24,427 | 27,422 | 23,701 | 22,555 | |||
| Prepaid expense | 6,784 | 6,195 | 4,711 | 3,963 | 2,251 | 3,531 | |||
| Other undisclosed current assets | 15,893 | 19,764 | 12,314 | 17,282 | 26,951 | 10,748 | |||
| Total current assets: | 1,034,409 | 1,111,529 | 1,073,526 | 999,441 | 439,947 | 321,369 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 34,835 | 23,596 | 18,267 | 19,009 | ✕ | ||||
| Property, plant and equipment | 51,479 | 32,678 | 22,693 | 11,395 | 9,342 | 8,442 | |||
| Other noncurrent assets | 14,022 | 11,161 | 12,086 | 10,908 | 4,904 | 2,945 | |||
| Other undisclosed noncurrent assets | 11,384 | 12,684 | 12,923 | 11,230 | 25,255 | 7,037 | |||
| Total noncurrent assets: | 111,720 | 80,119 | 65,969 | 52,542 | 39,501 | 18,424 | |||
| TOTAL ASSETS: | 1,146,129 | 1,191,648 | 1,139,495 | 1,051,983 | 479,448 | 339,793 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 153,757 | 132,089 | 119,043 | 90,507 | 62,528 | 43,457 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 39,590 | 30,316 | 20,904 | 16,717 | ||
| Accounts payable | 94,391 | 85,197 | 72,600 | 53,647 | 36,925 | 26,708 | |||
| Accrued liabilities | 59,366 | 46,892 | 6,853 | 6,544 | 4,699 | 32 | |||
| Deferred revenue | 16,224 | ✕ | |||||||
| Debt | 31 | ||||||||
| Other undisclosed current liabilities | 9,134 | 26,688 | 23,559 | 23,105 | 23,783 | 21,072 | |||
| Total current liabilities: | 179,115 | 158,777 | 142,602 | 113,612 | 86,311 | 64,560 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 568,822 | 565,509 | 575,213 | 444,198 | 149,424 | 149,268 | |||
| Long-term debt, excluding current maturities | 568,822 | 565,509 | 562,216 | 429,905 | 149,424 | 149,268 | |||
| Liabilities, other than long-term debt | 27,438 | 21,788 | 6,643 | 12,476 | 23,715 | 13,343 | |||
| Deferred revenue | 2,878 | 6,477 | 12,139 | ✕ | |||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 7,807 | |||
| Liability, pension and other postretirement and postemployment benefits | 15,686 | 12,249 | |||||||
| Other liabilities | 18 | 148 | 166 | 337 | 222 | 1,094 | |||
| Operating lease, liability | 27,420 | 18,762 | 12,997 | 14,293 | ✕ | ||||
| Other undisclosed noncurrent liabilities | 8,258 | 4,404 | 4,543 | 5,171 | 2,208 | 363 | |||
| Total noncurrent liabilities: | 604,518 | 591,701 | 586,399 | 461,845 | 175,347 | 162,974 | |||
| Total liabilities: | 783,633 | 750,478 | 729,001 | 575,457 | 261,658 | 227,534 | |||
| Equity | |||||||||
| Equity, attributable to parent | 362,496 | 441,170 | 410,494 | 476,526 | 217,790 | 112,259 | |||
| Additional paid in capital | 1,353,468 | 1,222,063 | 1,099,589 | 1,111,435 | 871,442 | 757,314 | |||
| Accumulated other comprehensive loss | (5,469) | (2,433) | (3,169) | (3,832) | (2,767) | (1,400) | |||
| Accumulated deficit | (985,503) | (778,460) | (685,926) | (631,077) | (650,885) | (643,655) | |||
| Total equity: | 362,496 | 441,170 | 410,494 | 476,526 | 217,790 | 112,259 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,146,129 | 1,191,648 | 1,139,495 | 1,051,983 | 479,448 | 339,793 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 509,338 | 537,840 | 535,031 | 494,366 | 351,318 | 248,069 | ||
| Cost of revenue | (128,280) | (114,867) | (114,877) | (106,501) | (88,606) | (80,048) | ||
| Gross profit: | 381,058 | 422,973 | 420,154 | 387,865 | 262,712 | 168,021 | ||
| Operating expenses | (613,928) | (512,496) | (464,487) | (357,464) | (263,626) | (201,693) | ||
| Operating income (loss): | (232,870) | (89,523) | (44,333) | 30,401 | (914) | (33,672) | ||
| Nonoperating income | 46,036 | 15,790 | ||||||
| Investment income, nonoperating | 46,036 | 15,790 | ||||||
| Interest and debt expense | (4,906) | (8,113) | (7,742) | (12,299) | (7,910) | (12,270) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (191,740) | (81,846) | (52,075) | 18,102 | (8,824) | (45,942) | ||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Income (loss) from continuing operations before income taxes: | (191,740) | (81,846) | (52,075) | 18,102 | (8,824) | (45,942) | ||
| Income tax expense (benefit) | (15,303) | (10,688) | (6,276) | 1,706 | 1,594 | (17,617) | ||
| Income (loss) from continuing operations: | (207,043) | (92,534) | (58,351) | 19,808 | (7,230) | (63,559) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (58,351) | 19,808 | (7,230) | (63,559) | |
| Net income (loss) available to common stockholders, diluted: | (207,043) | (92,534) | (58,351) | 19,808 | (7,230) | (63,559) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (207,043) | (92,534) | (58,351) | 19,808 | (7,230) | (63,559) | ||
| Other comprehensive income (loss) | (3,036) | 736 | 663 | (1,065) | (1,367) | (57) | ||
| Other undisclosed comprehensive loss | ||||||||
| Comprehensive income (loss): | (210,079) | (91,798) | (57,688) | 18,743 | (8,597) | (63,616) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | ||||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (210,079) | (91,798) | (57,688) | 18,743 | (8,597) | (63,616) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.